TRICORTIN®



International nonproprietary name

No




Dosage form

Solution for intramuscular administration 12 mg + 1 mg/2 ml

Compound

active substance - phospholipids of the pig cerebral cortex 12.00 mg, cyanocobalamin 1000.00 mcg,

excipients: lidocaine hydrochloride, disodium hydrogen phosphate dodecahydrate, 
sodium dihydrogen phosphate dihydrate, p-hydroxybenzoic acid esters, water for injection.

Description

A slightly opalescent red solution with a characteristic odor.

Pharmacotherapeutic group

Other psychostimulants and nootropics.

ATX code N06BX

Pharmacological properties

Pharmacokinetics

The metabolic targeting and stability of dual labeled phospholipids administered parenterally
have been studied through both total brain radioactivity and 3H/14C ratio trends at the cellular level.
Research shows that these molecules are stable at the hematological level and reach the brain as a whole.

Pharmacodynamics

Parenteral administration of pig cerebral cortex phospholipids (neurohomologous phospholipids) 
can activate neuronal metabolism, normalizing the enzymatic activity of the membrane, 
increase the turnover of neurotransmitters, glycide metabolism and one of the endogenous phospholipids.
Cyanocobalamin takes part as an auxiliary factor in the metabolism of nerve cells, performing a neurocytotrophic effect.

Indications for use

- polymyalgic neurosis syndrome

Directions for use and doses

2 ml is administered intramuscularly once a day as prescribed by the doctor.

Side effects

There have been no reported side effects that could be attributed to this drug.


Overdose

No overdose symptoms were reported.

Contraindications

- hypersensitivity to the components of the drug or other substances,

similar in chemical structure

- children and adolescents up to 18 years of age

Drug interactions

There have been no reports of interactions with other drugs.
There are no known cases of incompatibility of TRICORTIN® with other drugs.




Special instructions

Pregnancy and lactation

The drug can be administered during pregnancy and lactation under the direct supervision of a physician.

Features of the drug's influence on the ability to drive a vehicle or potentially dangerous machinery

The drug does not affect the ability to drive a car or operate machinery.

Форма выпуска и упаковка

По 2 мл в ампулы из оранжевого стекла тип I, с точкой для разлома.

По 5 ампул в контурную ячейковую упаковку из пленки поливинилхлоридной.

По 1 контурной ячейковой упаковке вместе с инструкцией по медицинскому применению на государственном и русском языках вкладывают в картонную коробку.

Условия хранения

Хранить при температуре не выше 25 °C

Хранить в недоступном для детей месте!

Срок хранения

2 года

Не применять по истечении срока годности!

Условия отпуска из аптек

По рецепту

Производитель/Упаковщик

Фидиа фармацеутиси Эс.Пи.Эй.,

35031, Абано Терме, Виа Понте делла Фаббрика, 3/А, Италия

Владелец регистрационного удостоверения

Фидиа фармацеутиси Эс.Пи.Эй.,

35031, Абано Терме, Виа Понте делла Фаббрика, 3/А, Италия